Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OSARTIS
Münster, Hessen, Germany
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
OSARTIS bone cements and biomaterials (e.g., BonOs®, BonOs® Inject, PerOssal®) are CE-marked, in commercial use and supported by clinical studies for safety and efficacy in orthopedic and spinal procedures; products show reliable performance in bone anchorage and drug delivery for infection management[1][3][6].
- Therapeutic areas
- Infectious DiseasesRheumatologyNeurology
- Modalities
- BiologicDeviceSynthetic oligonucleotidePolymer-drug conjugate therapy
- Industry
- Implantable Medical Devices
02
Partnerships
Tecres S.p.A. (through Demetra Holding)Global orthopedic companies (OEM partnerships; not specified)
Beyond the preview
Go deeper on OSARTIS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OSARTIS.